United States · FDA National Drug Code directory
STRENZA PLUS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73614-732_2df9064c-0528-4c21-e063-6294a90a56d8
- Product NDC
- 73614-732
- Form
- KIT
- Composition / generic term
- Moxifloxacin 0.5%, Bromfenac 0.09%, Prednisolone Acetate 1%
- Labeler
- Brisk Pharmaceuticals
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20250210
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (73614-732-03) * 5 mL in 1 BOTTLE, PLASTIC * 1 BOTTLE, DROPPER in 1 CARTON (72266-142-01) / 1.7 mL in 1 BOTTLE, DROPPER * 3 mL in 1 BOTTLE · 73614-732-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →